2012 NIDA International Forum: Speaker Presentations

If you would like to view these presentations, you may click on any of the links below to request a copy via email.

Friday, June 8, 2012

Workshop: Community Epidemiology Work Group (CEWG) and Network-Based Models for Monitoring Drug Abuse Trends

• Keeping Ahead of the Curve: Tracking Emerging Drug Issues in Texas
  Jane C. Maxwell, The University of Texas at Austin
• Applying Drug Abuse Work Group Findings to Information for Action in South Florida
  James N. Hall, Nova Southeastern University
• Developing National Drug Information Systems: An International Perspective
  Marya Hynes, Inter-American Drug Abuse Control Commission (CICAD)
• Networks Need Nurturing: Lessons Learnt From Developing Local, National, and European Drug Information Networks in Europe
  Jane Mounteney, EMCDDA
  Paul Griffiths, EMCDDA

NIDA International Fellowship Programs Alumni Meeting

• Opportunities for International Collaboration in Genetics and Drug Abuse Research
  Joni Rutter, Division of Basic Neuroscience and Behavioral Research, NIDA
• An Open Access Research Guide to Drug and Alcohol Studies: Supporting Information Needs in Developing Nations
  Nita Bryant, Virginia Commonwealth University
  Kim Brady, Virginia Commonwealth University
• International Society of Addiction Journal Editors (ISAJE) Writing Mentor Program
  Peter M. Miller, Medical University of South Carolina

Saturday, June 9, 2012

Welcoming Remarks

• College on Problems of Drug Dependence (CPDD)
  Jan Copeland, Chair, CPDD International Committee, and University of New South Wales, Australia

Plenary Addresses

• Current U.S. Strategy for Addressing Drug Abuse
  Cecilia McNamara Spitznas, Office of National Drug Control Policy
• New Psychoactive Substances—A Growing Challenge for Drug Policy and Practice
  Paul Griffiths, EMCDDA
• Capturing Emerging Synthetic Drug Trends in the United States: From the Border to the Controlled Substances Act
  Michelle D. Walker, Drug Enforcement Administration

New and Emerging Psychoactive Substances: Effects, Mechanisms of Action, and Detection

• Synthetic Cannabinoid Receptor Agonists: Methods of Detection and Current Knowledge on Toxicity
  Volker Auwaerter, University of Medical Center Freiburg, Germany
• Testing Strategies To Monitor Novel/Emerging Designer Drug Use in At-Risk Populations
  Barry Logan, National Medical Services Labs, Inc.

International Research Reports

• Naltrexone for Opioid Dependence: Oral, Implantable, and Injectable
  Evgeny Krupitsky, St. Petersburg Bekhterev Research Psychoneurological Institute and St. Petersburg State Pavlov Medical University, Russia
• Nonmedical Use of Prescription Drugs Among School Adolescents in Bogota, Colombia
  Catalina Lopez Quintero, Hebrew University, Israel
• A Mixed-Methods Approach To Identifying Factors Related to Voluntary HIV Testing Among Injection Drug Users in Shanghai, China
  Jiang Du, Shanghai Mental Health Center, China
• Therapeutic Justice in Sao Paulo City, Brazil: Analysis of Results From 2009
  Mario Sobrinho, Public Ministry of Sao Paulo, Brazil

New and Emerging Psychoactive Substances: Global Updates

• Update–European Union: Is the Future Already Here?
  Roumen Sedefov, EMCDDA
• Amphetamine-Type Drug Injectors in Post-Communist EurAsia: Different Drugs, Different Behaviors, Different Interventions?
  Tomas Zabransky, Charles University in Prague, Czech Republic
• Assessing and Monitoring Emerging Drug Trends in Australia
  Michael Farrell, National Drug and Alcohol Research Centre, Australia
• Changes in the Trends of the Abuse of Designer Drugs and Their Legal Status in Japan
  Ruri Kikura-Hanajiri, National Institute of Health Sciences, Japan

New and Emerging Psychoactive Substances: Implications for Prevention and Treatment

• New Drugs—New Prevention Strategies: The Polish Experience
  Artur Malczewski, National Bureau for Drug Prevention, Poland

Drugged Driving: Patterns, Impairment, And Policy Responses

• Impairment Versus Presence of Substances in Drugged Driving Policy
  Jorg Morland, Norwegian Institute for Public Health, Norway
• North Versus South: Driving Under the Influence of Alcohol in Low- and Middle-Income Countries of Latin America
  Flavio Pechansky, Federal University of Rio Grande do Sol, Brazil
• What We Do and Don’t Know About Drugged Driving
  Jane C. Maxwell, The University of Texas at Austin

Satellite Conference – Friday June 8, 2012

2012 International Women’s Fifth Meeting and Conference

• Women, Substance Abuse, Context, and Treatment: Global Issues
  Wendee M. Wechsberg, Research Triangle Institute
• The Early Environments of Children Born to Mothers Who Use Methamphetamine: A Comparison of Two Cultures
  Tricia Wouldes, The University of Auckland, New Zealand
• HIV Risks Among Women IDUs and Bridging Populations in St. Petersburg, Russia
  Olga Toussova, St. Petersburg State Medical University, Russia
• A Formative Study of Drug-Using Women in Georgia: Setting the Stage for an RCT
  Irma Kirtadze, Addiction Research Center, Georgia
• Sex/Gender Differences in Drug Abuse and Implications for Gender-Focused Treatment

  Cora Lee Wetherington, NIDA